Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06968494
NA

Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction

Sponsor: Comphya Inc.

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to assess if a new device is safe to use as a potential treatment for erectile dysfunction following radical prostatectomy. The main questions it aims to answer are: * Is the device safe? * Does the device works well? Are the participants satisfied with the device? Participants will be implanted with the device during the ongoing prostatectomy surgery and will be asked to complete the following tasks during 6 months follow-up: * Come to the hospital for follow-up visits, * Complete questionnaires, * Activate the device every day, * Measure erection hardness. Researchers will compare an implanted group (participants having the device) with a control group (participants not having the device) to see if the device works well.

Official title: Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Key Details

Gender

MALE

Age Range

30 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2025-06-05

Completion Date

2027-04

Last Updated

2025-11-10

Healthy Volunteers

No

Interventions

DEVICE

Activation of pro-erectile nerves within the pelvic plexus

The study device is an active implantable device. The device activates the pro-erectile nerves by delivering electrical pulses. The daily delivery of electrical pulses to the pro-erectile nerves may allow participants to recover natural erectile function.

Locations (1)

Johns Hopkins Hospital

Baltimore, Maryland, United States